Alfavision Overseas (India) Limited (BOM:531156)
9.16
-0.41 (-4.28%)
At close: May 29, 2026
BOM:531156 Market Cap
BOM:531156 has a market cap or net worth of 288.78 million as of June 1, 2026. Its market cap has decreased by -25.95% in one year.
Market Cap
288.78M
Enterprise Value
1.65B
Revenue
13.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.16
Market Cap Chart
Since October 21, 2004, BOM:531156's market cap has increased from 14.19M to 288.78M, an increase of 1,935.56%. That is a compound annual growth rate of 14.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 288.78M | 53.95% |
| Dec 31, 2025 | 187.58M | -57.19% |
| Dec 31, 2024 | 438.21M | -22.95% |
| Dec 29, 2023 | 568.73M | 43.63% |
| Dec 30, 2022 | 395.97M | 1.01% |
| Dec 31, 2021 | 392.03M | 328.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Resonance Specialties | 1.46B |
| Smruthi Organics | 1.41B |
| Tyche Industries | 1.40B |
| Krebs Biochemicals & Industries | 1.39B |
| Bacil Pharma | 718.08M |
| Vasundhara Rasayans | 473.23M |
| Crestchem | 372.00M |
| Venmax Drugs and Pharmaceuticals | 277.99M |